Novo Nordisk A/SPartnership with AWS to accelerate drug discovery via AI and cloud services.
Novo Nordisk has entered a strategic partnership with Amazon Web Services to accelerate drug discovery and modernize operations through artificial intelligence and cloud technology. The agreement makes AWS Novo Nordisk's preferred cloud provider and strategic AI partner, and the companies will open a co-innovation hub in London where AWS engineers and AI specialists will work alongside Novo Nordisk's research and development teams. The collaboration will use services including Amazon Bio Discovery, Amazon Bedrock and Amazon Bedrock AgentCore to analyze complex scientific data, identify potential drug targets and improve operational efficiency. Novo Nordisk says the partnership builds on an existing relationship that has already reduced clinical documentation time and improved productivity for more than 25,000 employees. Financial terms and quantified targets for research savings or development timelines were not disclosed.
Novo Nordisk A/SPartnership with AWS to accelerate drug discovery via AI and cloud services.
Amazon.com IncAWS selected as preferred cloud and AI partner, expanding its enterprise customer base.